Company: SREA
Filing Date: 2025-08-26
Form Type: 424B5
Source: 0001193125-25-188201
Chunk: 63

Company: SEMPRA
Filing Date: 2025-08-26
Form: 424B5
Chunk 63
---
 by a Relevant Person which is:

| (a) | a corporation (which is not an Accredited Investor), the sole business of which is to hold investments and the 
 entire share capital of which is owned by one or more individuals, each of whom is an Accredited Investor; or  |

| (b) | a trust (where the trustee is not an Accredited Investor), the sole purpose of which is to hold investments and 
 each beneficiary of the trust is an individual who is an Accredited Investor,                                   |

the securities or securities-based derivatives contracts (each as defined in Section 2(1) of the SFA) of that corporation, and the beneficiaries’ rights and interest (howsoever described) in that trust, shall not be transferred within six months after that corporation or that trust has subscribed for or acquired the notes except:

| (1) | to an Institutional Investor, an Accredited Investor or other Relevant Person, or which arises from an offer                                 
 referred to in Section 275(1A) of the SFA (in the case of that corporation) or Section 276(4)(c)(ii) of the SFA (in the case of that trust); |

| (2) | where no consideration is or will be given for the transfer; |

| (3) | where the transfer occurs by operation of law; or |

| (4) | as specified in Section 276(7) of the SFA. |

Singapore’s Securities and Futures Act Product Classification—Solely for the purposes of its obligations pursuant to Sections 309B(1)(a) and 309B(1)(c) of the SFA, Sempra has determined, and hereby notifies all relevant persons (as defined in Section 309A of the SFA) that the notes are “prescribed capital markets products” (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018) and “Excluded Investment Products” (as defined in MAS Notice SFA 04-N12:Notice on the Sale of Investment Products and MAS Notice FAA-N16:Notice on Recommendations on Investment Products). Switzerland This prospectus supplement and the accompanying prospectus are not intended to constitute an offer or solicitation to purchase or invest in the notes. The notes may not be publicly offered, directly or indirectly, in Switzerland within the meaning of the Swiss Financial Services Act (“FinSA”) and no application has or will be made to admit the notes to trading on any trading venue (exchange or mult